[ET Net News Agency, 6 February 2024] EVEREST MED-B (01952) rose 10.5% to HK$16.06.
It hits an intra-day high of HK$16.06, and an intra-day low of HK$14.52. The total
shares traded was 3.61 million, with a value of HK$55.99m. The active buy/sell ratio is
62:38, with net buying turnover of HK$13.32m. J.P. MORGAN BRO (HK) accounts for greatest
net responsive buying turnover of HK$2.2m, with volume weighted average price of
HK$15.576. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling
turnover of HK$7.4m, with volume weighted average price of HK$15.458.
Basic Information
=================
----------------------------------
Nominal 16.060 % Chg +10.45%
High 16.060 Low 14.520
Shares Tr 3.61m Turnover 55.99m
10-D SMA 16.424 %H.V 62.590
20-D SMA 17.520 VWAP 15.497
50-D SMA 18.845 RSI14 40.994
----------------------------------
Status: Active buy/sell ratio is 62:38, with net buying turnover of HK$13.32m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 16.06 +10.45
GENSCRIPT BIO (01548) 13.90 +8.42
INNOVENT BIO (01801) 32.80 +8.97
JXR (01951) 2.28 +6.54
WUXI BIO (02269) 18.08 +4.51
WUXI APPTEC (02359) 48.75 +7.26
BEIGENE (06160) 89.30 +2.94
ZAI LAB (09688) 17.58 +1.62
AKESO (09926) 42.05 +7.96
INNOCARE (09969) 4.99 +2.25
---------------------------------------------
(ed)